Sandoz Plugs Ophthalmology Gap With Coherus Ranibizumab Deal

Deal Includes $170m Upfront; Coherus Pushing Into Novel Oncology Space

M&A
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products